Related references
Note: Only part of the references are listed.Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome
Marry H. Nieuwenhuis et al.
FAMILIAL CANCER (2014)
Incidence of Colonic Neoplasia in Patients With Serrated Polyposis Syndrome Who Undergo Annual Endoscopic Surveillance
Yark Hazewinkel et al.
GASTROENTEROLOGY (2014)
Somatic Mutations in MLH1 and MSH2 Are a Frequent Cause of Mismatch-Repair Deficiency in Lynch Syndrome-Like Tumors
Arjen R. Mensenkamp et al.
GASTROENTEROLOGY (2014)
New insights into POLE and POLD1 germline mutations in familial colorectal cancer and polyposis
Laura Valle et al.
HUMAN MOLECULAR GENETICS (2014)
A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer
David Mesher et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Colorectal cancer risk variants on 11q23 and 15q13 are associated with unexplained adenomatous polyposis
Frederik J. Hes et al.
JOURNAL OF MEDICAL GENETICS (2014)
Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'Care for CMMRD' (C4CMMRD)
Katharina Wimmer et al.
JOURNAL OF MEDICAL GENETICS (2014)
Guidelines for surveillance of individuals with constitutional mismatch repair-deficiency proposed by the European Consortium Care for CMMR-D (C4CMMR-D)
H. F. A. Vasen et al.
JOURNAL OF MEDICAL GENETICS (2014)
Systematic review of the impact of registration and screening on colorectal cancer incidence and mortality in familial adenomatous polyposis and Lynch syndrome
P. Barrow et al.
BRITISH JOURNAL OF SURGERY (2013)
Serrated Polyposis: Colonic Phenotype, Extracolonic Features, and Familial Risk in a Large Cohort
Kory W. Jasperson et al.
DISEASES OF THE COLON & RECTUM (2013)
EPCAM deletion carriers constitute a unique subgroup of Lynch syndrome patients
Marjolijn J. L. Ligtenberg et al.
FAMILIAL CANCER (2013)
The mechanism of mismatch repair and the functional analysis of mismatch repair defects in Lynch syndrome
Juana V. Martin-Lopez et al.
FAMILIAL CANCER (2013)
How do we approach the goal of identifying everybody with Lynch Syndrome?
Heather Hampel et al.
FAMILIAL CANCER (2013)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Hans F. A. Vasen et al.
GUT (2013)
High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome
Virginie Bubien et al.
JOURNAL OF MEDICAL GENETICS (2013)
Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
Claire Palles et al.
NATURE GENETICS (2013)
Cancer Risks for Relatives of Patients With Serrated Polyposis
Aung Ko Win et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Phenotype and Polyp Landscape in Serrated Polyposis Syndrome: A Series of 100 Patients From Genetics Clinics
Christophe Rosty et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Lifetime Cancer Risks in Individuals with Germline PTEN Mutations
Min-Han Tan et al.
CLINICAL CANCER RESEARCH (2012)
Is colorectal surveillance indicated in patients with PTEN mutations?
M. H. Nieuwenhuis et al.
COLORECTAL DISEASE (2012)
Risks of Less Common Cancers in Proven Mutation Carriers With Lynch Syndrome
Christoph Engel et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation
Frank Schwenter et al.
JOURNAL OF GASTROENTEROLOGY (2012)
Hereditary mixed polyposis syndrome is caused by a 40-kb upstream duplication that leads to increased and ectopic expression of the BMP antagonist GREM1
Emma Jaeger et al.
NATURE GENETICS (2012)
High Cumulative Risk of Intussusception in Patients With Peutz-Jeghers Syndrome: Time to Update Surveillance Guidelines?
M. G. F. van Lier et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Evaluation of management of desmoid tumours associated with familial adenomatous polyposis in Dutch patients
M. H. Nieuwenhuis et al.
BRITISH JOURNAL OF CANCER (2011)
MUTYH-associated polyposis (MAP)
Maartje Nielsen et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
John Burn et al.
LANCET (2011)
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Marlies J. E. Kempers et al.
LANCET ONCOLOGY (2011)
Lynch syndrome-how should colorectal cancer be managed?
Hans F. A. Vasen et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
High Cancer Risk in Peutz-Jeghers Syndrome: A Systematic Review and Surveillance Recommendations
M. G. F. van Lier et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants
E. Theodoratou et al.
BRITISH JOURNAL OF CANCER (2010)
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe
H. F. A. Vasen et al.
FAMILIAL CANCER (2010)
Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome
K. S. Boparai et al.
GUT (2010)
Peutz-Jeghers syndrome: a systematic review and recommendations for management
A. D. Beggs et al.
GUT (2010)
Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers
Laura Baglietto et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
MUTYH-associated polyposis
Julian R. Sampson et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2009)
Hamartomatous polyposis syndromes
Amanda Gammon et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2009)
Germ-Line Mutations in Mismatch Repair Genes Associated with Prostate Cancer
Eli Marie Grindedal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
E. Barrow et al.
CLINICAL GENETICS (2009)
Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications
H. T. Lynch et al.
CLINICAL GENETICS (2009)
Genotype Predicting Phenotype in Familial Adenomatous Polyposis: A Practical Application to the Choice of Surgery
Marry H. Nieuwenhuis et al.
DISEASES OF THE COLON & RECTUM (2009)
Expanded Extracolonic Tumor Spectrum in MUTYH-Associated Polyposis
Stefanie Vogt et al.
GASTROENTEROLOGY (2009)
Deletions Removing the Last Exon of TACSTD1 Constitute a Distinct Class of Mutations Predisposing to Lynch Syndrome
Marietta E. Kovacs et al.
HUMAN MUTATION (2009)
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3 ' exons of TACSTD1
Marjolijn J. L. Ligtenberg et al.
NATURE GENETICS (2009)
Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin
Cristiane H. Squarize et al.
CANCER RESEARCH (2008)
Validation and extension of the PREMM1,2 model in a population- based cohort of colorectal cancer patients
Francesc Balaguer et al.
GASTROENTEROLOGY (2008)
Hyperplastic Polyps and Sessile Serrated Adenomas as a Phenotypic Expression of MYH-Associated Polyposis
Karam S. Boparai et al.
GASTROENTEROLOGY (2008)
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
Leigha Senter et al.
GASTROENTEROLOGY (2008)
A high incidence of MSH6 mutations in Amsterdam criteria II-negative families tested in a diagnostic setting
D. Ramsoekh et al.
GUT (2008)
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
H. F. A. Vasen et al.
GUT (2008)
Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg?
Katharina Wimmer et al.
HUMAN GENETICS (2008)
Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome
John Burn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Risk of colorectal cancer in juvenile polyposis
Lodewiik A. A. Brosens et al.
GUT (2007)
Family history is neglected in the work-up of patients with colorectal cancer:: a quality assessment using cancer registry data
D. A. van Dijk et al.
FAMILIAL CANCER (2007)
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
H. F. A. Vasen et al.
JOURNAL OF MEDICAL GENETICS (2007)
Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome
Isis Dove-Edwin et al.
GASTROENTEROLOGY (2006)
Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function
X Cao et al.
JOURNAL OF MEDICAL GENETICS (2006)
Desmoid tumors - a characterization of patients seen at Mayo Clinic 1976-1999
Taya Fallen et al.
FAMILIAL CANCER (2006)
Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
H Hampel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency - Familial colorectal cancer type X
NM Lindor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer
V Piñol et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Sertoli cell tumor causing prepubertal gynecomastia in a boy with Peutz-Jeghers syndrome: The outcome of 1-year treatment with the aromatase inhibitor testolactone
C Kara et al.
HORMONE RESEARCH (2005)
High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors
A Hansmann et al.
CANCER (2004)
The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations
JR Howe et al.
JOURNAL OF MEDICAL GENETICS (2004)
Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations:: Impact on counseling and surveillance
YMC Hendriks et al.
GASTROENTEROLOGY (2004)
Genomic medicine - Hereditary colorectal cancer
HT Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Juvenile polyposis:: massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers
W Friedl et al.
HUMAN GENETICS (2002)
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis
RKS Phillips et al.
GUT (2002)
Primary chemoprevention of familial adenomatous polyposis with sulindac
FM Giardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
